InhalPlus

Pioneering respiratory care

The core problem in pulmonary drug delivery is inefficiency: too little medication reaches the lungs, reducing efficacy, while excessive systemic exposure causes significant side effects. We address this gap with an inhalation-based therapy that overcomes dilution in the ventilatory circuit. Our hardware-driven system delivers a highly concentrated aerosol directly to the patient, bypassing the limitations of current methods. It integrates seamlessly with existing hospital equipment and workflows, enabling targeted pulmonary drug delivery without systemic burden. In short, we make inhaled therapy effective where it previously failed, with the goal of replacing burdensome and invasive procedures.